As of June 2026, 19 paid clinical trials are recruiting in Hillsborough, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hillsborough offers studies at sites including University of North Carolina-Hillsborough Campus for conditions such as Becker Muscular Dystrophy, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Hillsborough has approximately 19 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Researchers run research studies in Hillsborough, NC at 13 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of North Carolina-Hillsborough Campus | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 6 |
| Rare Disease Research, LLC | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, DMD | 2 |
| Rare Disease Research | Angelman Syndrome | 1 |
| Rare Disease Research Center | Becker Muscular Dystrophy, Duchenne Muscular Dystrophy | 1 |
| Rare Disease Research NC, LLC | Spinal Muscular Atrophy (SMA) | 1 |
| Rare Disease Research, LLC NC | Becker Muscular Dystrophy | 1 |
| UNC Hospitals - Hillsborough Campus | Lumbar Spinal Stenosis | 1 |
| UNC Hospitals Hillsborough Campus | Pneumonia | 1 |
| University Of North Carolina Health Care - Hillsborough Campus | Multiple Myeloma | 1 |
| University of North Carolina - Hillsborough Campus | IUD Insertion Pain | 1 |
| University of North Carolina Hospitals - Hillsborough Campus | Cutaneous Melanoma, Stage II | 1 |
| University of North Carolina Hospitals at Hillsborough | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | 1 |
| University of North Carolina at Chapel Hill | Colo-rectal Cancer | 1 |
Recruiting trials in Hillsborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Hillsborough from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 19 recruiting clinical trials in Hillsborough, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Hillsborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Hillsborough include Becker Muscular Dystrophy (2), Advanced Esophageal Adenocarcinoma (1), Advanced Gastric Adenocarcinoma (1), Advanced Gastroesophageal Junction Adenocarcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hillsborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Hillsborough include University of North Carolina-Hillsborough Campus, Rare Disease Research, LLC, Rare Disease Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Hillsborough are Cancer & tumors (8), Neurology & pain (1), Pediatric (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.